Recruiting

Observational Study

Sponsor:

University of Alberta

Code:

NCT06924671

Conditions

Low Back Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GLA:D Back

Study Details

Brief summary:

GLA:D Back is a program developed in Denmark to help people with persistent low back pain. This study will assist in contextualizing Danish content into an English version of the program.

Conditions

Low Back Pain

Study ID

NCT06924671

Start date

Jun 18, 2021

Status verified date

Apr, 2026

Completion date

Jun, 2027

Anticipated

Primary completion date

Feb, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients must have persistent low back pain of at least 1 month's duration.

Exclusion Criteria:

  • Participating currently in a supervised exercise or rehabilitation program or enrolled in another interventional clinical trial.
  • Patients with nerve root involvement, suspected serious pathology, unstable trauma to the spine, aspects of pregnancy or other conditions that would prevent participation or disallow trial completion within the prescribed time period.
  • Persons with conditions that require a specialist consult are suspected of needing a specialist consult, or have conditions that would be aggravated or worsened if treated by the interventions in this study.

Study Design

Enrollment

2200 participants

Anticipated

Interventions and Outcome Measures

Interventions

GLA:D Back

GLA:D Back is a 10-week program based on first-line recommendations of patient education and structured exercise taught in a group format.

Primary outcome measure

  • Implementation [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Locations

University of Alberta

Recruiting

Edmonton, Alberta, Canada, T6G 2G4

Contacts

More Information

Sponsor

University of Alberta

Last update posted

Apr 13, 2026

Last verified

Apr, 2026

Keywords

  • Low Back Pain

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Alberta on 2026-04-13.